FDA Approved: LYLLANA — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for LYLLANA (estradiol) submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Postmenopausal Osteoporosis
• Vasomotor Symptoms
• Vulvar and Vaginal Atrophy

Drugs mentioned

• LYLLANA (ESTRADIOL)

Snippet

SUPPL AP for LYLLANA (ESTRADIOL)